No abstract available
MeSH terms
-
1-Methyl-4-phenylpyridinium / adverse effects
-
Adrenal Glands / transplantation
-
Adult
-
Antiparkinson Agents / adverse effects
-
Antiparkinson Agents / therapeutic use
-
Brain Chemistry
-
Child
-
Child, Preschool
-
Cytoplasmic Granules / pathology
-
Dyskinesia, Drug-Induced / etiology
-
Environmental Pollutants / adverse effects
-
Fetus
-
Humans
-
Levodopa / adverse effects
-
Levodopa / therapeutic use
-
Middle Aged
-
Palliative Care
-
Parkinson Disease* / diagnosis
-
Parkinson Disease* / drug therapy
-
Parkinson Disease* / epidemiology
-
Parkinson Disease* / etiology
-
Prevalence
-
Research
-
Selegiline / therapeutic use
-
Substantia Nigra / drug effects
-
Substantia Nigra / pathology
-
Substantia Nigra / transplantation
-
Time Factors
Substances
-
Antiparkinson Agents
-
Environmental Pollutants
-
Selegiline
-
Levodopa
-
1-Methyl-4-phenylpyridinium